Granting of Stock Options and Vesting of Restricted Share Units

Rhea-AI Summary

Alvotech (ALVO) has announced the granting of stock options to four independent board directors and the vesting of previously awarded Restricted Share Units (RSUs). Each director received options to purchase 24,784 Alvotech shares at an exercise price of $9.28 per share.

The stock options will vest over a three-year period, with one-third vesting each year starting from the grant date of June 25, 2025. Directors must remain board members at the time of vesting to exercise their options. The exercise price was determined by the opening price of Alvotech's ordinary shares on Nasdaq US on the grant date.

News Market Reaction – ALVO

-1.54%

-1.54% Session move

In the trading session that priced this news, ALVO declined 1.54%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

In accordance with the Remuneration Policy of Alvotech (the “Company”), which was approved at the Company’s Annual General Meeting (“AGM”) on June 6, 2023, at the 2025 AGM held on June 25, 2025, four independent board directors each received a stock option grant allowing the purchase of up to 24,784 Alvotech shares.

The aim of the stock option grants is to align the long-term interests of the board members and the Company. The relevant key terms and conditions of the Company´s Equity Incentive Plan approved by Alvotech’s Annual and Extraordinary General Meeting on June 13, 2022 are as follows:

• The stock option agreements entitle the grantee to purchase Alvotech shares at an exercise price of USD 9.28 per share*.
• The options are subject to a vesting period over three years with yearly vesting, i.e. one third of the options vest each year starting on the AGM where the stock options were awarded.  
• The options are only exercisable if the grantee is still a member of the board of Alvotech at the time of vesting.

Attached to this announcement are filings with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) made by the respective four independent board directors of their vested RSUs, in accordance with previous grants.

*The exercise price is determined by the opening price of the Company's ordinary shares on the Nasdaq US stock exchange on the date of the grant, in this case on June 25, 2025. 

Alvotech Investor Relations
Benedikt Stefansson, VP
alvotech.ir@alvotech.com

Attachments

• Notification_Managers Transaction_Ann Merchant
• Notification_Managers Transaction_Hjörleifur Pálsson
• Notification_Managers Transaction_Lisa Graver
• Notification_Managers Transaction_Richard Davies

FAQ

How many Alvotech (ALVO) stock options were granted to each independent board director?

Each of the four independent board directors received options to purchase 24,784 Alvotech shares at an exercise price of $9.28 per share.

What is the vesting schedule for Alvotech's (ALVO) board director stock options granted in 2025?

The options vest over a three-year period, with one-third vesting each year starting from the grant date of June 25, 2025.

What is the exercise price for Alvotech's (ALVO) 2025 board director stock options?

The exercise price is $9.28 per share, determined by the opening price of Alvotech's shares on Nasdaq US on June 25, 2025.

What are the conditions for Alvotech (ALVO) board directors to exercise their stock options?

Directors must remain members of the board at the time of vesting to exercise their options.